Domain's Portfolio Companies Had Nine Products Approved in 2014

February 23, 2015

Domain Associates prides itself on a track record of supporting companies that bring products all the way to the market to help patients. 2014 was an unprecedented year with nine product approvals, including two novel anti-infective agents and a novel diagnostic test to detect acute kidney injury.
More »

Domain's Top 10 Portfolio Company Stories 2014

February 23, 2015

A number of our portfolio companies made headlines this year. Here a just a few of those stories.
More »

Spotlight on Achillion Pharmaceuticals’ Phase 2 Clinical Data

February 19, 2015

Achillion announced promising Phase 2 clinical trial data this month. The goal of the trial is to evaluate their candidate, ACH-3102, in patients with hepatitis C.
More »

ROX Medical Rocks Hypertension Device Trial

January 23, 2015

ROX Medical developed the ROX Coupler to help treat patients who are unable to control their hypertension. In a recent clinical trial, published Jan 22, 2015 in The Lancet, researchers found that the ROX Coupler significantly reduced blood pressure in patients with uncontrolled hypertension.
More »

IntegenX’s Rapid Human DNA Identification System Helps Law Enforcement Find the Right Suspect

December 3, 2014

More »